Answers are grounded in this paper and cite their sources.
Nefopam hydrochloride is extensively used in most of the European countries until today as an analgesic because of its non-opiate (non-narcotic) and non-steroidal action with fewer side effects compared with opioid and other analgesics, which cause more troublesome side effects. A multikilogram synthesis of nefopam hydrochloride has been achieved in one pot using a single solvent (toluene). A ≥99.9% purity of the active pharmaceutical ingredient (API) was achieved in excellent overall yield (≥79%). The one-pot, five-step synthetic process involves formation of an acid chloride ( 3 ) from benzoylbenzoic acid ( 2 ) followed by amidation ( 4 ), reduction ( 5 ), cyclization ( 6 ), and formation of the hydrochloride salt ( 1 ). The major advantages include (i) use of a single solvent, (ii) >90% conversion in each step, (iii) a cost-effective and operationally friendly process, (iv) averting the formation of genotoxic impurities, and (v) improved overall yield (≥79%) provided by the one-pot operation. For the first time, we report the characterization data of API 1, intermediates 3, 4, and 5, and also a possible impurity ( 5a ).
No takes yet. Share an insight, caveat, or question.
Krishnaiah et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: